Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

raltegravir

raltegravir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Isentress TABLET, ORAL 400 mg    
Isentress HD TABLET, ORAL 600 mg      
VIEW MORE HIV Integrase Inhibitors
CLASS
08180812
Comments:

Pregancy: Isentress HD 600 mg is not recommended in pregnant patients.  Pregnant patients should use their own supply of raltegravir 400 mg.  A short course (1-2 days) of Isentress HD 600 mg per the below interchange may be used until the patient can obtain the home supply.

Ordered Formulation Therapeutic Interchange

raltegravir (Isentress)

  • 400 mg PO tablet BID                                                               

raltegravir (Isentress HD)

  • 2x 600 mg PO tablet ONCE Daily (Total: 1,200 mg)

Reviewed: January 22, 2008 (Isentress), and 26 Sept 2017 (Isentress HD)

Last updated: Jun. 12, 2020






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved